Bibliography for: "Sepracor, King to slash sales forces"

McGuire, Stephen "Sepracor, King to slash sales forces". Medical Marketing and Media. FindArticles.com. 29 Nov, 2009. http://findarticles.com/p/articles/mi_qa5351/is_200712/ai_n21300534/

Medical Marketing and Media

View more issues:

Articles in Dec 2007 issue of Medical Marketing and Media

• CommonHealth shutters Adient, restructures
  by Iskowitz, Marc
• Pfizer set to take CME in new direction
  by Iskowitz, Marc
• J&J seeks to boost stent with DTC ads
  by Arnold, Matthew
• Novartis targets oncologists with blog
  by Arnold, Matthew
• Others
• Calendar
• certainty of uncertainty, The
  by Chase, James
• FDA creates pediatric review agency
  by Dickinson, James G
• Federal preemption fails in award against Wyeth products
  by Dickinson, James G
• PR View
  by Bashe, Gil
• Cardiovascular
• MEDIA
• Judge tosses J&J logo claim
  by McGuire, Stephen
• MEDIA NOTEPAD: Update
• Web Watch
  by McKillen, Dan
• Rozerem takes prize in bad ad award
  by Arnold, Matthew
• RUBIN'S RUBRIC
  by Ross, Warren
• Respiratory
• Pharma's chagrin: NDA approvals on decline in 2007
  by Iskowitz, Marc
• Bill would kill drug market exclusivity
  by Dickinson, James G
• Elsevier launches Clinical Solutions
  by Arnold, Matthew
• DDMAC to Scios: halt Natrecor promo
  by McGuire, Stephen
• ACCME firewall letter sent, but not sealed
  by Iskowitz, Marc
• UPWARD MOVE
• NAME THAT BRAND
• NEWS: Update
• WASHINGTON INSIDER: Update
• Google's health initiative expected to launch in '08
  by McGuire, Stephen
• Sepracor, King to slash sales forces
  by McGuire, Stephen
• Diabetes
• AGENCIES
• Viewpoint
  by Kamp, John
• Drug ad violations rising, biologics numbers down
  by Dickinson, James G
• CME REPORT: Update
• WebMD, Yahoo! sign exclusive deal
  by McGuire, Stephen
• WALL STREET CHOICE: MERCK SETTLES VIOXX LIABILITY FOR $4.85 BILLION
• ELECTILE DYSFUNCTION
  by Arnold, Matthew
• COMPANY NEWS
• ACCME appoints Singer bias monitor
  by Iskowitz, Marc
• Antidote
• DIRECT MARKETING: Update
• Pfizer pfudges with its withdrawl of Exubera
  by Iskowitz, Marc
• Central Nervous System
• PRIVATE VIEW
  by Moss, Michele
• Pipeline
• Advanstar enlists Deal to lead MedEc
  by Arnold, Matthew
• Credentialers take another step
  by Iskowitz, Marc
• Emotional techniques build brands' personality
  by Iskowitz, Marc
• Davidson bested anti-ad Goliaths
  by Arnold, Matthew
• MANUFACTURERS
• Takeda looks to distance Actos from Avandia in ads
  by Arnold, Matthew
• Takeda debuts 'Move to Amitiza' DTC
  by Arnold, Matthew
• Guidance issued on joint sponsorship
  by Iskowitz, Marc
• DTC REPORT: Update
• Vantage Point
  by Vanderveer, Richard B
• AT WORK WITH...
• Plus ça change....
  by Ross, Warren
• As I See It
  by Dickinson, James G
• MEDIA CHOICE
• Cegedim Dendrite enlists FDA expert
  by McGuire, Stephen
• TNS quantifies Avandia cardiac toll
  by Iskowitz, Marc
• Oncology
• SUPPLIERS
• Does tracking Web traffic jam ads?
  by Calabrese, Steve; Davies, Melissa; Petrini, Carolina; Saville, Shelby
• Roche swings MM&M Gold Award on 'Happy Feet' tie-in
  by Iskowitz, Marc; Arnold, Matthew